UBS Group AG - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$36,400,000
+183.7%
2,405,832
+40.6%
0.02%
+220.0%
Q2 2022$12,830,000
-12.4%
1,710,637
+6.3%
0.01%0.0%
Q1 2022$14,650,000
+30420.8%
1,609,856
+23326.3%
0.01%
Q4 2021$48,000
+29.7%
6,872
+113.0%
0.00%
Q3 2021$37,000
-95.9%
3,227
-94.3%
0.00%
Q2 2021$905,000
+635.8%
56,515
+721.4%
0.00%
Q1 2021$123,000
+95.2%
6,880
+46.7%
0.00%
Q4 2020$63,000
-55.0%
4,691
-60.4%
0.00%
Q3 2020$140,000
+26.1%
11,853
+56.7%
0.00%
Q2 2020$111,000
-98.4%
7,566
-98.5%
0.00%
-100.0%
Q1 2020$6,802,000
-40.9%
503,873
+5.7%
0.00%0.0%
Q4 2019$11,518,000
+60521.1%
476,557
+47555.7%
0.00%
Q3 2019$19,000
-36.7%
1,0000.0%0.00%
Q2 2019$30,000
-64.3%
1,000
-42.9%
0.00%
Q1 2019$84,000
-33.3%
1,752
-49.9%
0.00%
Q4 2018$126,000
-74.9%
3,500
-57.1%
0.00%
Q3 2018$502,000
-80.0%
8,161
-78.0%
0.00%
-100.0%
Q2 2018$2,504,000
+390.0%
37,074
+294.0%
0.00%
Q1 2018$511,000
+120.3%
9,409
+142.3%
0.00%
Q4 2017$232,000
-92.0%
3,883
-93.5%
0.00%
-100.0%
Q3 2017$2,895,000
+3709.2%
59,588
+4009.5%
0.00%
Q2 2017$76,000
-33.3%
1,450
-42.5%
0.00%
Q1 2017$114,000
+17.5%
2,523
-2.0%
0.00%
Q4 2016$97,000
+24.4%
2,575
+23.6%
0.00%
Q3 2016$78,000
+457.1%
2,083
+160.4%
0.00%
Q2 2016$14,000
+250.0%
800
+166.7%
0.00%
Q1 2016$4,000
-84.0%
300
-71.0%
0.00%
Q4 2015$25,000
+78.6%
1,036
+29.5%
0.00%
Q3 2015$14,000
-83.5%
800
-83.4%
0.00%
Q2 2015$85,000
+240.0%
4,819
+502.4%
0.00%
Q1 2015$25,000
-67.1%
800
-69.1%
0.00%
Q4 2014$76,0002,5890.00%
Other shareholders

There were no reported owners of AERIE PHARMACEUTICALS INC in Q3 2021.

NameSharesValueWeighting ↓
View complete list of AERIE PHARMACEUTICALS INC shareholders